Skip To Main Content
PET Radiopharmaceuticals on Muck Rack

PET Radiopharmaceuticals

As seen in: Frontiers, GlobeNewswire, Benzinga, EIN News, openPR, EIN Presswire, World'vest Base (WVB), South Jordan Journal, TechTrends
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to PET Radiopharmaceuticals’s profile

Articles by PET Radiopharmaceuticals

Preoperative correlations between glymphatic function and glucose metabolism in drug-resistant temporal lobe epilepsy: divergent patterns and postoperative outcomes

|
By PET Radiopharmaceuticals
| TechTrends
Background Brain glymphatic dysfunction may impair cerebral metabolism and contribute to surgical prognosis in Temporal Lobe Epilepsy (TLE). Purpose To evaluate presurgical glymphatic dysfunction in TLE using the diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) index and determine its correlation with cerebral glucose metabolism in patients with different surgical outcomes.
Open in Who Shared Issue with article?

Nuclear Medicine Diagnostics Market 2023 : Analysis By Top Major Players, Drivers, Trends And Overview Till 2032

|
By PET Radiopharmaceuticals, Research Institutes
| openPR
Nuclear Medicine Diagnostics Market Growth The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 The Business Research Company's Nuclear Medicine Diagnostics Global Market Report 2023 identifies increasing demand for nuclear medicine diagnostics as the major driver for the Nuclear Medicine Diagnostics market's growth in the forecast period.
Open in Who Shared View Duplicates (56) Issue with article?

Nuclear Medicine Diagnostics Market Size, Share And Growth Original

|
By PET Radiopharmaceuticals, Research Institutes
| GlobeNewswire
LONDON, June 22, 2023 (GLOBE NEWSWIRE) -- As per The Business Research Company’s Nuclear Medicine Diagnostics Global Market Report 2023, the market will grow from $5.9 billion in 2022 to $6.5 billion in 2023 at a compound annual growth rate (CAGR) of more than 11%. Further, the market size will reach $9.8 billion in 2027 at a CAGR of more than 10%.
Open in Who Shared View Duplicates (29) Issue with article?

Nuclear Medicine Diagnostics Market Size, Share And Growth Analysis For 2023-2032 As Per The Business Research Company's Nuclear Medicine Diagnostics Global Market Report 2023

|
By PET Radiopharmaceuticals, Research Institutes
| EIN News
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 /EIN News/ -- LONDON, June 22, 2023 (GLOBE NEWSWIRE) -- As per The Business Research Company’s Nuclear Medicine Diagnostics Global Market Report 2023, the market will grow from $5.9 billion in 2022 to $6.5 billion in 2023 at a compound annual growth rate (CAGR) of more than 11%.
Open in Who Shared View Duplicates (31) Issue with article?

Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review

|
By Stephanie Ameis, James Robert Brasic, PET Radiopharmaceuticals
| Frontiers
Autism Spectrum Disorder Autism spectrum disorder (ASD) is a pervasive developmental disorder characterized by persistently impaired social interactions and interpersonal communication, limited, repetitive, and stereotyped behaviors, and a significantly limited range of interests and activities. In 2013, the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) revolutionized the diagnostic criteria for ASD (American Psychiatric Association, 2013).
Open in Who Shared Issue with article?
Show More